Broad therapeutic treatment window of [Nle4, D-Phe7]α-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils-Reference-Cited by-同舟云学术

Broad therapeutic treatment window of [Nle4, D-Phe7]α-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils

Published:2006-05 Issue:1-3 Volume:538 Page:48-56
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Giuliani Daniela,Leone Sheila,Mioni Chiara,Bazzani Carla,Zaffe Davide,Botticelli Annibale R.,Altavilla Domenica,Galantucci Maria,Minutoli Letteria,Bitto Alessandra,Squadrito Francesco,Guarini Salvatore

Publisher

Elsevier BV

Subject

Pharmacology

Reference64 articles.

1. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment;Adams;Stroke,1993

2. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats;Amemiya;Eur. J. Pharmacol.,2005

3. Neuronal replacement from endogenous precursors in the adult brain after stroke;Arvidsson;Nat. Med.,2002

4. Protective effect of melanocortin peptides in rat myocardial ischemia;Bazzani;J. Pharmacol. Exp. Ther.,2001

5. Involvement of the central nervous system in the protective effect of melanocortins in myocardial ischaemia/reperfusion injury;Bazzani;Resuscitation,2002

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanocortin-receptor 4 activation modulates proliferation and differentiation of rat postnatal hippocampal neural precursor cells;Neuropharmacology;2024-10

2. A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial;BMC Neurology;2023-07-26

3. A Feasibility and Safety Study of Afamelanotide in Acute Stroke Patients – An Open Label, Proof of Concept, Phase Iia Clinical Trial;2022-11-28

4. Using dual polarities of transcranial direct current stimulation in global cerebral ischemia and its following reperfusion period attenuates neuronal injury;Metabolic Brain Disease;2022-05-02

5. A Single Immediate Use of the Cathodal Transcranial Direct Current Stimulation Induces Neuroprotection of Hippocampal Region Against Global Cerebral Ischemia;Journal of Stroke and Cerebrovascular Diseases;2022-03